![]()
29
| 3 | 2009
Klinisk Biokemi i Norden
Foto: Henrik Alfthan
Beskrivelse av Eldjarn-prisen
1. “The Lorentz Eldjarn Prize Competition for Best
Publication”, hereafter referred to as “The Prize”
is financed by the Lorentz Eldjarn Fund, esta-
blished by Professor Lorentz Eldjarn and his wife
Torunn in 2009. The Prize is intended to support
and promote the international distribution of the
journal “The Scandinavian Journal of Clinical
and Laboratory Investigation” (hereafter referred
to as “SJCLI”). Lorentz Eldjarn was the Managing
Editor of SJCLI during 16 years.
2. The Prize is awarded each second year to the
first author of the best article published in SJCLI
during the five years proceeding the prize year.
At least one of the authors has to be engaged in
activities related to medical biochemistry at an
institution in one of the Nordic countries.
3. The twenty most cited articles during the actual
five year period are pre-selected for further evalu-
ation by a Prize Committee. The Prize Committee
nominates three of the pre-selected articles to be
presented at the forthcoming Nordic Congress in
Clinical Chemistry.
4. The first author of each of the three nominated
articles are invited to present their study as a part
of the scientific program at the Nordic Congress
of Clinical Chemistry, especially focussing on the
scientific impact of the study on the development
within the actual field of research. The nominees
shall also focus on how the actual article has
influenced their own later works.
5. The members of the Prize Committee are selec-
ted among the Editorial Board of SJCLI by the
Managing Editor of SJCLI, with one member
from each of Denmark, Finland, Norway and
Sweden. Additionally, the Managing Editor is
member and Chairman of the Prize Committee.
6. In addition to nominating the final three articles,
the Price Committee is also responsible for the
pre-selection process, for arranging the final pre-
sentations and for the contact with the nominees.
7. Based on the scientific quality of the study and the
clarity of the presentations the Prize Committee
shall reach a consensus on the recipient of the
first, the second and the third prize.
8. The recipients of the Prize shall be announced
by the Chairman of the Prize Committee at
the banquet of the Nordic Congress in Clinical
Chemistry.
9. The 1. Prize winner receives DKR100.000, the
2. Prize winner receives DKR 50.000 and the 3.
Prize winner receives DKR 30.000. Each of the
recipients will also receive a certificate citing their
contributions. The Board of The Lorentz Eldjarn
Fund may regulate the amount of awarded money
depending on the financial situation of the Fund.
10. The Lorentz Eldjarn Fund will pay the travel
expenses, accommodation for three nights and
the congress fee for the three nominees and the
Prize Committee.
11. The Prize Committee shall present a summary
report to “The Lorentz Eldjarn Fund” within two
months after the awarding
